Skip to main content
. Author manuscript; available in PMC: 2015 Nov 23.
Published in final edited form as: J Drug Target. 2009 Jun;17(5):364–373. doi: 10.1080/10611860902807046

Figure 7.

Figure 7

Transfection activity of rSDN in B16F10 and THLE-3 cells. (a) THLE-3 cells without chloroquine; (b) THLE-3 cells with 100 µM chloroquine; (c) B16F10 without chloroquine; (d) B16F10 cells with 100 µM chloroquine. Transfection was measured in the presence (black bar) or absence of (white bar) of competing free RGD. (# p-value > 0.05; * p-value < 0.05, n=4)